BioSpace News Archive

Boehringer Ingelheim, a global leader in veterinary rabies vaccines2, plans to donate 60,000 doses of its IMRAB® rabies vaccine for dogs over the next three years to fight rabies in Puerto Rico.

Curis, Inc. announced that James Dentzer, Chief Executive Officer of Curis, will present at the Cantor Fitzgerald Global Healthcare Conference on Thursday, October 3, 2019 at 3:00 p.m. ET in New York, NY.

Executive team addition reinforces increased investment in AI, machine learning and analytics-enabled solutions to improve patient access and outcomes

Caligan Partners LP, one of the largest shareholders of AMAG Pharmaceuticals, Inc., issued a letter to AMAG shareholders in connection with its campaign to replace four directors of AMAG.

Currax Pharmaceuticals LLC announced a deal whereby Currax obtained patent rights to ONZETRA® Xsail® in North America from OptiNose AS, a subsidiary of OptiNose, Inc..

Flatiron Health announced 13 abstracts accepted for presentation at the European Society for Medical Oncology Congress 2019, which will be held September 27 – October 1, 2019, in Barcelona, Spain.

Tangible® Science, an innovator creating a dramatically better contact lens experience for patients and eye care practices, announced the launch of Unity® BioSync™ Contact Lenses.

Centene Corporation and WellCare Health Plans, Inc. announced that, in connection with the previously announced merger agreement between Centene and WellCare, a subsidiary of WellCare has entered into a definitive agreement under which Anthem, Inc. will acquire WellCare’s Missouri and Nebraska Medicaid plans.

GE Renewable Energy’s Grid Solutions business announced plans to invest tens of millions of dollars to expand its range of sulfur hexafluoride-free high-voltage substation equipment to include all key high-voltage levels by 2025.

VoP Report was recently published on the FDA website, highlights the results of the Externally-led Patient-Focused Drug Development (PFDD) Meeting [26-September-2019] NEW YORK , Sept. 26, 2019 /PRNewswire/ -- The Hereditary Neuropathy Foundation (HNF) is proud to share the Voice of the Patient (VoP) Report which was recently published on the FDA website. The report hi